NEW YORK (GenomeWeb News) – Israeli seed and breeding technology firm Kaiima Bio Agri-Tech today announced it closed on a financing round that raised US$65 million.

Three new investors participated in the round — Horizons Ventures; the International Financial Corporation, a member of the World Bank Group; and the Infinity Group. Participating existing investors included Draper Fisher Jurvetson; DFJ-Tamir Fishman Ventures; Mitsui Global Investment; Kleiner Perkins Caufield & Byers; Oberlee; and Musea Ventures.

Kaiima did not specify how the financing will be used.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: variant linked to canine cleft lip, new compression tool, and more.

GNC will start using DNA testing to authentic the presence of plants included in its labels, following an agreement with the New York Attorney General.

Fareed Zakaria writes that instead of focusing solely on STEM-related courses, students would do well to pursue the liberal arts if they want to be technology innovators.

A Harvard Business Review study found four major patterns of gender biases and added that black and Latina scientists further had to navigate racial stereotypes.